pharmaphorum March 19, 2025
Phil Taylor

Google gave an update on various aspects of its health-related R&D at its annual event The Check Up, including a new collection of artificial intelligence (AI) models intended to support drug discovery.

The TxGemma models are – as the name suggests – an offshoot of Google’s Gemma family of open-source, generative AI (GenAI) models that are, in turn, based on its Gemini AI platform, the latest iteration of which launched in December.

The toolkit is due to be made available to the scientific community for appraisal and further development later this month through its Health AI Developer Foundations programme, although it’s not clear yet whether they can be used and adapted for commercial applications.

According to Google’s chief health officer...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
We spoke to 40+ customers of AI agents — here’s where the tech is falling short
Report: Perplexity in Talks to Raise Up to $1 Billion
AI in Primary Care: Reducing Burnout and Empowering Physicians
How AI is transforming GI operating rooms
Guideline highlights AI's role in colonoscopy, but calls for more research

Share This Article